Letters Aspirin “resistance”

What is the risk of cardiovascular morbidity?

BMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39479.465706.3A (Published 07 February 2008) Cite this as: BMJ 2008;336:291
  1. Peter Elwood, honorary professor,
  2. Gareth Morgan, secretary, Welsh Aspirin Group
  1. 1Department of Primary Care and Public Health, Cardiff University Cardiff CF10 3XQ
  1. pelwood{at}doctors.org.uk

    The increased risk of vascular disease in a subgroup of patients judged to be “resistant” to aspirin led Krasopoulos et al to propose that there could be beneficial effect of aspirin of greater than 50% in aspirin sensitive patients.1

    The problem is identifying subjects “resistant” to aspirin. Krasopoulos et al accepted evidence from the authors of 20 …

    View Full Text

    Sign in

    Log in through your institution

    Subscribe